Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125171093 | 12517109 | 3 | F | 20160809 | 20160630 | 20160817 | EXP | US-PFIZER INC-2016318044 | PFIZER | FARAJI, F.. BLINDNESS RESULTING FROM BISPHOSPHONATE RELATED OSTEONECROSIS OF THE SKULL BASE. JOURNAL OF NEUROLOGICAL SURGERY. PART B: SKULL BASE. 2016;77 (SUPPL 1):P022 | 69.00 | YR | M | Y | 0.00000 | 20160817 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125171093 | 12517109 | 1 | PS | ZOLEDRONIC ACID | ZOLEDRONIC ACID | 1 | UNK | U | 90621 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125171093 | 12517109 | 1 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125171093 | 12517109 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125171093 | 12517109 | Blindness unilateral | |
| 125171093 | 12517109 | Exophthalmos | |
| 125171093 | 12517109 | Eye movement disorder | |
| 125171093 | 12517109 | Eyelid ptosis | |
| 125171093 | 12517109 | Osteomyelitis | |
| 125171093 | 12517109 | Osteonecrosis of jaw |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |